SEC Form 4 · accession 0001106578-26-000135
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Sep 3, 2026
Accepted (ET)
Sep 4, 2026 · 4:31 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 3, 2026 | M | 8,910 | $135.42 | A | 333,353 | I | by Trust |
| Common StockF2 | Sep 3, 2026 | M | 590 | $117.76 | A | 333,943 | I | by Trust |
| Common StockF3,F2 | Sep 3, 2026 | S | 200 | $479.066 | D | 333,743 | I | by Trust |
| Common StockF4,F2 | Sep 3, 2026 | S | 440 | $480.5257 | D | 333,303 | I | by Trust |
| Common StockF5,F2 | Sep 3, 2026 | S | 600 | $481.4726 | D | 332,703 | I | by Trust |
| Common StockF6,F2 | Sep 3, 2026 | S | 400 | $482.345 | D | 332,303 | I | by Trust |
| Common StockF7,F2 | Sep 3, 2026 | S | 80 | $483.69 | D | 332,223 | I | by Trust |
| Common StockF8,F2 | Sep 3, 2026 | S | 240 | $485.1585 | D | 331,983 | I | by Trust |
| Common StockF9,F2 | Sep 3, 2026 | S | 411 | $486.724 | D | 331,572 | I | by Trust |
| Common StockF10,F2 | Sep 3, 2026 | S | 1,429 | $487.8655 | D | 330,143 | I | by Trust |
| Common StockF11,F2 | Sep 3, 2026 | S | 1,604 | $488.6827 | D | 328,539 | I | by Trust |
| Common StockF12,F2 | Sep 3, 2026 | S | 3,114 | $489.6169 | D | 325,425 | I | by Trust |
| Common StockF13,F2 | Sep 3, 2026 | S | 940 | $490.5004 | D | 324,485 | I | by Trust |
| Common StockF14,F2 | Sep 3, 2026 | S | 42 | $491.2452 | D | 324,443 | I | by Trust |
| Common Stock | holding | — | — | — | 40,513 | D | ||
| Common Stock | holding | — | — | — | 166 | I | by Spouse | |
| Common StockF15 | holding | — | — | — | 249,108 | I | by Trust | |
| Common StockF16 | holding | — | — | — | 45,596 | I | by Trust | |
| Common StockF17 | holding | — | — | — | 8,902 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF18 | $135.42 | Sep 3, 2026 | M | 8,910 | D | Mar 15, 2023 | Mar 15, 2027 | Common Stock | 8,910 | 0 | I |
| Stock OptionF18,F19 | $117.76 | Sep 3, 2026 | M | 590 | D | — | Mar 15, 2027 | Common Stock | 590 | 499,410 | I |
Explanation of responses
- F1This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10This transaction was executed in multiple trades at prices ranging from $487.18 to $488.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11This transaction was executed in multiple trades at prices ranging from $488.18 to $489.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12This transaction was executed in multiple trades at prices ranging from $489.18 to $490.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13This transaction was executed in multiple trades at prices ranging from $490.18 to $491.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14This transaction was executed in multiple trades at prices ranging from $491.23 to $491.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F16Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F17Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F18Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F19These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F2Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3This transaction was executed in multiple trades at prices ranging from $478.44 to $479.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $479.97 to $480.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $481.05 to $482.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $482.12 to $482.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $483.55 to $483.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $484.92 to $485.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $486.18 to $487.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.